ESRD Network 13 Medwatch Database
To Search the ESRD Network 13 FDA Medwatch Database click here.
ESRD’s FDA Medwatch Listing
| 12/16/2015 | FDA MedWatch – Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS) |
| 12/11/2015 | FDA MedWatch – November 2015 Drug Safety Labeling Changes includes 19 products with revisions to Prescribing Information |
| 12/04/2015 | FDA MedWatch – SGLT2 Inhibitors: Drug Safety Communication – Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections |
| 12/02/2015 | FDA MedWatch – OmniPod Insulin Management System by Insulet: Field Safety Notification – Reported Cases of Needle Mechanism Deployment Failure or Delay |
| 11/27/2015 | FDA MedWatch – Compounded Multivitamins by Glades Drugs: Voluntary Recall – High Amounts of Vitamin D3 (Cholecalciferol) |
| 11/25/2015 | Recall: Baxter 15L Cycler Drainage Bags |
| 11/23/2015 | FDA MedWatch – Intravascular Medical Devices: FDA Safety Communication – Lubricious Coating Separation |
| 11/13/2015 | FDA MedWatch – October 2015 Drug Safety Labeling Changes includes 26 products with revisions to Prescribing Information |
| 11/06/2015 | FDA MedWatch – Plavix (clopidogrel): Drug Safety Communication – Long-term Treatment Does Not Change Risk of Death |
| 10/29/2015 | FDA MedWatch – Auvi-Q (epinephrine injection, USP): Recall – Potential Inaccurate Dosage Delivery |
